Skip to main content
17 February, 2020

Generon - Hyris

Hyris and Generon: new strategic cooperation agreement.

The Hyris platform offers the unique capability to perform full genetic analysis of biological samples in any kind of setting. It incorporates all the needed hardware, software and reagents and can be used as a fully portable testing laboratory to provide highly accurate results, reducing the time associated with traditional methods.

To continue their expansion in the field of genetic analysis Hyris and Generon have signed a strategic cooperation agreement.

Generon is a leader of systems based on the most modern analytical technologies, included Real-Time PCR assays. Generon produces a high-quality analysis kit for the detection of food pathogens, food allergens, GMO, and food authenticity. Several years of experience in the field of agri-food quality control guarantee advantages in the specificity, sensitivity, rapidity, and reliability of its solutions.

The collaboration between Hyris and Generon increases the application portfolio available on the platform while provide specific solutions in the fast-growing food testing market.


Visit the Generon website for more info



  • Hyris signs a distribution agreement with GrowBIGogh

  • Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

  • Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

  • Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

  • Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

  • Hyris' new onboarding programs support researchers and developers to launch testing kits.

  • Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

  • Hyris and Singlabs signed a distributorship agreement for Singapore

  • Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

  • Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine